| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.58B | +31.9% |
| Cost of Revenue | $281.1M | +26.9% |
| R&D Expense | $319.9M | +41.5% |
| SG&A Expense | $525.2M | +40.2% |
| Operating Income | $113.7M | -8.9% |
| Pre-tax Income | $127.4M | +4.4% |
| Income Tax | $74.0M | +570.5% |
| Net Income | $53.4M | -61.2% |
| EPS (Basic) | $0.11 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.03B | +36.6% |
| Short-term Investments | $416.1M | +103.3% |
| Accounts Receivable | $2.35B | +16.2% |
| Current Assets | $3.85B | +24.4% |
| Total Assets | $4.38B | +22.5% |
| Current Liabilities | $2.03B | +12.5% |
| Total Liabilities | $2.27B | +10.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $548.7M | +45.0% |
| Capital Expenditures | $84.2M | +53.6% |
| Investing Cash Flow | -$304.4M | -225.1% |
| Financing Cash Flow | $32.0M | +0.2% |
| Free Cash Flow | $464.6M | +43.5% |
| -62.1% |
| EPS (Diluted) | $0.11 | -60.7% |
| Stockholders' Equity |
| $2.12B |
| +38.5% |